Systematic review: Cardiovascular safety profile of 5-HT 4 agonists developed for gastrointestinal disorders

2012

Background The nonselective 5-HT4 receptor agonists, cisapride and tegaserod have been associated with cardiovascular adverse events (AEs).

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

215

References

204

Citations